STAT

3 China biotech stories to watch in 2019

In 2018, biotech in China generated relentless news. What's next for 2019?

As 2019 begins, STAT reporters are taking a look at the stories they’re most eager to track during the year. Find all our “three to watch” series here

This past year has often felt like the year that China’s biotech sector finally arrived. After years of punching below its weight, in 2018 the industry generated relentless news, milestones, and investment going in both directions across the Pacific.

You're reading a preview, sign up to read more.

More from STAT

STAT4 min readSociety
Opinion: It’s Time To Change The Definition Of ‘Health’
Rather than pursuing the "absence" of disease, we need a more inclusive definition of health — one that works for more people.
STAT4 min read
Opinion: State Drug Importation Programs Will Work With The FDA, Not Outside Of It
State programs can use the global pharmaceutical supply chain to relieve the sometimes crushing financial burden of drug treatments — at least until we have an effective national approach to…
STAT5 min readSociety
Opinion: I Wanted To Try Medical Marijuana. Why Couldn’t My Doctors Help Me?
Until we make it easier to study the effects of #medicalmarijuana and #cannabis, and train doctors about its benefits and risks, people who could benefit from it will continue to…